Barrington Research Upgrades Anika Therapeutics (ANIK) to Outperform
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.50 +1.13%
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Rating Summary:
4 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 13 | New: 20
Join SI Premium – FREE
Barrington Research analyst Michael Petusky upgraded Anika Therapeutics (NASDAQ: ANIK) from Market Perform to Outperform with a price target of $43.00.
For an analyst ratings summary and ratings history on Anika Therapeutics click here. For more ratings news on Anika Therapeutics click here.
Shares of Anika Therapeutics closed at $39.27 yesterday.
You May Also Be Interested In
- Freedom Broker Upgrades John B. Sanfilippo & Son, Inc. (JBSS) to Buy
- JPMorgan Upgrades Deterra Royalties Ltd (DRR:AU) to Overweight
- BofA Securities Upgrades Etsy (ETSY) to Buy, 'Still Room to Run'
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
